Numerous molecular markers and prognostic indicators such as carcinoembryonic antigen (CEA), RAS, BRAF mutation, tumor location, and microsatellite instability (MSI) can be used to determine metastatic colon cancer (mCC) prognosis. The gene discussed is CEACAM5; the disease is neoplasm.